Catherine Mazzacco - Mar 6, 2023 Form 3 Insider Report for Krystal Biotech, Inc. (KRYS)

Role
Director
Signature
/s/ Krish Krishnan, as attorney-in-fact for Catherine Mazzacco
Stock symbol
KRYS
Transactions as of
Mar 6, 2023
Transactions value $
$0
Form type
3
Date filed
3/9/2023, 05:26 PM
Next filing
Apr 4, 2023

No securities are beneficially owned.